ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients

ClinicalTrials.gov ID: NCT00082628

Public ClinicalTrials.gov record NCT00082628. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 4:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety and Efficacy of Serostim®, r-hGH in the Treatment and Maintenance of Human Immunodeficiency HIV-Associated Adipose Redistribution Syndrome, or HARS

Study identification

NCT ID
NCT00082628
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
EMD Serono
Industry
Enrollment
326 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Serostim® 2 mg Drug
  • Serostim® 4 mg Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 27, 2004
Primary completion
Sep 27, 2005
Completion
Sep 27, 2005
Last update posted
Jul 19, 2018

2004 – 2005

United States locations

U.S. sites
30
U.S. states
14
U.S. cities
25
Facility City State ZIP Site status
University of Alabama/Birmingham Birmingham Alabama 35294
CARE CLINIC - UCLA Medical Center Los Angeles California 90095
1401 N. Palm Canyon Palm Springs California 92262
Trials Unit Div of Infectious and Immunologic Diseases Sacramento California 95817
UCSD - AntiViral Research Center San Diego California 92103
University of California, San Francisco - Div. of Endocrinology San Francisco California 94110
Kaiser Permanente San Francisco California 94118
Northern California Institute for Research and Education, Inc. San Francisco California 94121
Harbor-UCLA Medical Ctr Research & Education Institute Torrance California 90502
AIDS Alliance West Hollywood California 90069
University of Colorado Health Sciences Center Denver Colorado 80262
1640 Rhode Island Avenue, N.W. Washington D.C. District of Columbia 20036
Office Of Dr Gary Richmond Fort Lauderdale Florida 33316
3661 South Miami Avenue Miami Florida 33133
Care Resources Miami Florida 33137
Infectious Disease Associates Sarasota Florida 34239
AIDS Research Consortium of Atlanta Atlanta Georgia 30308
Rush University Medical Center Chicago Illinois 60612
Indiana University Infectious Disease Research Clinic Indianapolis Indiana 46202
Tufts University School of Medicine Boston Massachusetts 02111
Community Research Initiative of New England Boston Massachusetts 02215
Community Research Initiative Of New England Springfield Massachusetts 01107
Hennepin County Medical Center Minneapolis Minnesota 55415
Albany Medical College Albany New York 12208
Weill Medical College of Cornell Universtiy New York New York 10021
St. Luke's Roosevelt Hospital New York New York 10025
Bronx Women's Interagency HIV Study The Bronx New York 10467
Central Texas Clincial research Austin Texas 78705
IDP Research Annandale Virginia 22003
Office of Daniel Coulston, M.D. Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00082628, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 19, 2018 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00082628 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →